Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFuture Regulatory News (FUTR)

Share Price Information for Future (FUTR)

Share Price is delayed by 15 minutes
Get Live Data
298.40    6.40 (2.19%)
Bid:
296.20
Ask:
297.20
Spread: 1.00 (0.338%)
Market Cap: £268.39m
FUTR Live PriceLast checked at - London Stock Exchange

Intraday Future Share Chart

Director/PDMR Shareholding

13 Dec 2024 10:34

RNS Number : 0545Q
Future PLC
13 December 2024
 

Date: 13 December 2024

 

 

 

Future plc

(the "Company")

 

Director/PDMR holding

 

 

Performance Share Plan (PSP)

On 12 December 2024, in accordance with the provisions of the Company's approved Remuneration Policy, an award was made of the following nil-cost options over Ordinary Shares of 15p each in the Company ("Shares") under the terms of the Future plc 2023 Performance Share Plan ("PSP"). This award will normally vest on the third anniversary of grant. The award under the PSP is subject to performance conditions (as set out on page 102 of the Company's Annual Report & Accounts for FY2024) and a holding period applies to the Executive Directors from the vesting date in respect of any Shares which vest under this award.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

 

Sharjeel Suleman

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

 

Chief Financial Officer (PDMR)

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

 

Future plc

b)

 

LEI

 

 

 

213800K2581YRLEXV353

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 15p each

Identification code

GB00BYZN9041

b)

 

Nature of the transaction

 

 

Grant of nil cost options over Future plc Shares under the PSP. The award will vest on the third anniversary of the date of grant, subject to the performance conditions, relating to the Company's relative TSR, adjusted diluted EPS and organic revenue growth for the year ended 30 September 2027, as are set out on page 102 of the Company's Annual Report & Accounts for FY2024.

 

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

70,705

d)

 

Aggregated information

N/A (single transaction)

- Aggregated volume

- Price

e)

 

Date of the transaction

 

12 December 2024

f)

 

Place of the transaction

 

London

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBGBDDDXBDGSX
Date   Source Headline
19th May 20228:12 amRNSDirector/PDMR Shareholding
18th May 20227:00 amRNSHalf Year Results
12th May 202210:37 amRNSHolding(s) in Company
10th May 20227:00 amRNSAcquisition of WhoWhatWear
29th Apr 20229:49 amRNSTotal Voting Rights
19th Apr 202211:00 amRNSNotice of Results
31st Mar 202211:03 amRNSTotal Voting Rights
24th Mar 20227:00 amRNSAcquisitions of WhatCulture.com & Waive
28th Feb 202210:28 amRNSTotal Voting Rights
17th Feb 20227:00 amRNSFurther re Rule 19.6(c) confirmation
11th Feb 202210:07 amRNSHolding(s) in Company
11th Feb 202210:06 amRNSDirector/PDMR Shareholding
8th Feb 20228:49 amRNSInvestor webinar
3rd Feb 20221:38 pmRNSDirector/PDMR Shareholding
3rd Feb 20221:36 pmRNSResult of AGM
3rd Feb 20227:00 amRNSTrading Update
31st Jan 20229:52 amRNSTotal Voting Rights
31st Jan 20229:51 amRNSHolding(s) in Company
25th Jan 202212:00 pmRNSInvestor webinar
17th Jan 20223:45 pmRNSHolding(s) in Company
4th Jan 202210:58 amRNSBlock listing Interim Review
4th Jan 202210:54 amRNSTotal Voting Rights
17th Dec 202111:52 amRNSAdditional Listing
15th Dec 20217:00 amRNSDirector/PDMR Shareholding
14th Dec 20213:58 pmRNSAnnual Financial Report
9th Dec 20217:00 amRNSLaunch of Responsibility Strategy
1st Dec 202110:47 amRNSTotal Voting Rights
30th Nov 20217:00 amRNSFull Year Results
1st Nov 20213:35 pmRNSTotal Voting Rights
14th Oct 202111:00 amRNSAppointment of Joint Corporate Broker
4th Oct 20217:00 amRNSFull-year performance update & directorate change
1st Oct 20219:21 amRNSTotal Voting Rights
24th Sep 202111:00 amRNSInvestor Webinar
1st Sep 20219:26 amRNSTotal Voting Rights
19th Aug 20219:45 amRNSHolding(s) in Company
16th Aug 20217:00 amRNSAcquisition of Dennis
2nd Aug 20217:00 amRNSTotal Voting Rights and Share Capital
26th Jul 202112:20 pmRNSDirector Declaration
21st Jul 20217:00 amRNSTrading Update
15th Jul 202110:14 amRNSDirector Declaration
1st Jul 20219:30 amRNSBlock listing Interim Review
1st Jul 20219:28 amRNSTotal Voting Rights
10th Jun 20212:59 pmRNSHolding(s) in Company
4th Jun 20217:00 amRNSDirector/PDMR Shareholding
3rd Jun 20215:21 pmRNSDirector/PDMR Shareholding
3rd Jun 20218:35 amRNSHolding(s) in Company
1st Jun 20219:08 amRNSTotal Voting Rights
26th May 20214:21 pmRNSHolding(s) in Company
19th May 20217:00 amRNSHalf Year Results
12th May 20217:00 amRNSAcquisition of Marie-Claire US

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.